Volume 46 - Article 31 | Pages 905–918  

The contribution of smoking-attributable mortality to differences in mortality and life expectancy among US African-American and white adults, 2000–2019

By Brian L. Rostron, Cindy M. Chang, Brittny C. Davis Lynn, Chunfeng Ren, Esther Salazar, Bridget K. Ambrose

Abstract

Background: The role of smoking in racial disparities in mortality and life expectancy in the United States has been examined previously, but up-to-date estimates are generally unavailable, even though smoking prevalence has declined in recent decades.

Objective: We estimate the contribution of smoking-attributable mortality to observed differences in mortality and life expectancy for US African-American and white adults from 2000–2019.

Methods: The indirect Preston–Glei–Wilmoth method was used with national vital statistics and population data and nationally representative never-smoker lung cancer death rates to estimate the smoking-attributable fraction (SAF) of deaths in the United States by sex-race group from 2000–2019. Mortality rates without smoking-attributable mortality were used to estimate life expectancy at age 50 (e_50) by group during the period.

Results: African-American men had the highest estimated SAF during the period, beginning at 26.4% (95% CI:25.0%–27.8%) in 2000 and ending at 12.1% (95% CI:11.4%–12.8%) in 2019. The proportion of the difference in e_50 for white and African-American men that was due to smoking decreased from 27.7% to 14.8%. For African-American and white women, the estimated differences in e_50 without smoking-attributable mortality were similar to observed differences.

Conclusions: Smoking continues to contribute to racial disparities in mortality and life expectancy among men in the United States.

Contribution: We present updated estimates of the contribution of smoking to mortality differences in the United States using nationally representative data sources.

Author’s Affiliation

• Brian L. Rostron - US Food and Drug Administration, United States of America EMAIL
• Cindy M. Chang - US Food and Drug Administration, United States of America EMAIL
• Brittny C. Davis Lynn - US Food and Drug Administration, United States of America EMAIL
• Chunfeng Ren - US Food and Drug Administration, United States of America EMAIL
• Esther Salazar - US Food and Drug Administration, United States of America EMAIL
• Bridget K. Ambrose - US Food and Drug Administration, United States of America EMAIL

Other articles by the same author/authors in Demographic Research

A modified new method for estimating smoking-attributable mortality in high-income countries
Volume 23 - Article 14

Similar articles in Demographic Research

Bayesian multidimensional mortality reconstruction
Volume 54 - Article 28    | Keywords: Bayesian reconstruction, data lack, hierarchical modelling, mortality

Winter life expectancy reduction in Europe
Volume 54 - Article 26    | Keywords: Europe, excess winter deaths, excess winter mortality paradox, life expectancy, mortality, summer, weekly mortality data, winter

Bringing cause-of-death analysis into demography: An interview with France Meslé
Volume 54 - Article 24    | Keywords: causes of death, epidemiological transition, health transition, mortality, mortality data

Refining seasonal mortality estimates through age adjustment: Evidence from Serbia, 2015–2023
Volume 54 - Article 15    | Keywords: age adjustment, excess mortality, life expectancy, mortality, mortality estimates, seasonal fluctuations, Serbia

Feminicide as a determinant of Mexican female life expectancy in the 21st century
Volume 53 - Article 24    | Keywords: female life expectancy, feminicide, life expectancy, Mexico, mortality, violence, women